The American Antidote for Chinese Lithium?
Switching to renewable energy means lithium demand could skyrocket 1,000% by 2030. But China controls 80% of the world's lithium supply, and the U.S. warns that China's monopoly is a national security and economic threat. Nevada's famed lithium deposits could be the best antidote to fight back against Chinese lithium domination.
See Why Nevada Lithium Should be on Your Radar

ALZN Insider Trading (Alzamend Neuro)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $8,148,453.66
Insider Selling (Last 12 Months): $81,200.00

Alzamend Neuro Insider Trading History Chart

This chart shows the insider buying and selling history at Alzamend Neuro by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alzamend Neuro Share Price & Price History

Current Price: $0.92
Price Change: Price Decrease of -0.01 (-1.07%)
As of 05/16/2022 01:00 AM ET

This chart shows the closing price history over time for ALZN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Options Expert is Giving Everything Away!
Trading champion Chuck Hughes has exposed the strategies of successful traders and handing them over to new traders like you!

His guide “Options Trading Made Easy” now comes with a Trade of the Day from Chuck himself to help you develop a profitable, pro-level trading account!
Get your copy today!

Alzamend Neuro Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2022Milton C. Ault IIIMajor ShareholderBuy25,000$0.85$21,250.009,791,667View SEC Filing Icon  
5/5/2022Milton C. Ault IIIMajor ShareholderBuy100,000$1.07$107,000.00325,000View SEC Filing Icon  
4/26/2022Milton C. Ault IIIMajor ShareholderBuy2,666,667$1.50$4,000,000.509,666,667View SEC Filing Icon  
4/22/2022Milton C. Ault IIIMajor ShareholderBuy75,000$0.94$70,500.00225,000View SEC Filing Icon  
4/11/2022Milton C. Ault IIIMajor ShareholderBuy50,000$1.13$56,500.00150,000View SEC Filing Icon  
3/31/2022Mark GustafsonDirectorSell20,000$1.21$24,200.0060,000View SEC Filing Icon  
3/18/2022Milton C. Ault IIIMajor ShareholderBuy100,000$1.10$110,000.00View SEC Filing Icon  
2/24/2022Milton C. Ault IIIMajor ShareholderBuy22,500$1.15$25,875.00View SEC Filing Icon  
1/27/2022Milton C. Ault IIIMajor ShareholderBuy2,500$1.40$3,500.00View SEC Filing Icon  
1/24/2022Milton C. Ault IIIMajor ShareholderBuy5,000$1.29$6,450.00View SEC Filing Icon  
1/18/2022Milton C. Ault IIIMajor ShareholderBuy7,000$1.66$11,620.00View SEC Filing Icon  
1/14/2022Milton C. Ault IIIMajor ShareholderBuy3,000$1.79$5,370.00View SEC Filing Icon  
1/7/2022Milton C. Ault IIIMajor ShareholderBuy3,000$1.93$5,790.00View SEC Filing Icon  
1/5/2022Milton C. Ault IIIMajor ShareholderBuy2,000$1.98$3,960.00View SEC Filing Icon  
12/23/2021Milton C. Ault IIIMajor ShareholderBuy1,612$2.10$3,385.20View SEC Filing Icon  
12/20/2021Milton C. Ault IIIMajor ShareholderBuy25,000$2.11$52,750.00View SEC Filing Icon  
12/17/2021Milton C. Ault IIIMajor ShareholderBuy13,000$2.48$32,240.00View SEC Filing Icon  
12/14/2021Mark GustafsonDirectorSell20,000$2.85$57,000.00View SEC Filing Icon  
11/30/2021Milton C. Ault IIIMajor ShareholderBuy5,319$2.27$12,074.13View SEC Filing Icon  
11/22/2021Milton C. Ault IIIMajor ShareholderBuy15,000$1.90$28,500.00View SEC Filing Icon  
11/8/2021Milton C. Ault IIIMajor ShareholderBuy145,000$2.57$372,650.00View SEC Filing Icon  
9/14/2021Milton C. Ault IIIMajor ShareholderBuy5,000$2.70$13,500.00150,000View SEC Filing Icon  
8/27/2021Milton C. Ault IIIMajor ShareholderBuy6,000$2.90$17,400.00View SEC Filing Icon  
8/17/2021Milton C. Ault IIIMajor ShareholderBuy4,000$3.29$13,160.00View SEC Filing Icon  
8/12/2021Milton C. Ault IIIMajor ShareholderBuy3,400$3.87$13,158.00View SEC Filing Icon  
8/9/2021Milton C. Ault IIIMajor ShareholderBuy500$4.05$2,025.00View SEC Filing Icon  
8/6/2021Milton C. Ault IIIMajor ShareholderBuy4,000$4.07$16,280.00View SEC Filing Icon  
8/4/2021Milton C. Ault IIIMajor ShareholderBuy500$4.30$2,150.00View SEC Filing Icon  
8/2/2021Milton C. Ault IIIMajor ShareholderBuy1,500$4.56$6,840.00View SEC Filing Icon  
7/30/2021Milton C. Ault IIIMajor ShareholderBuy1,338,333$1.51$2,020,882.83View SEC Filing Icon  
7/26/2021Milton C. Ault IIIMajor ShareholderBuy3,500$4.94$17,290.00View SEC Filing Icon  
7/23/2021Milton C. Ault IIIMajor ShareholderBuy5,000$5.76$28,800.00View SEC Filing Icon  
7/19/2021Milton C. Ault IIIMajor ShareholderBuy4,000$5.41$21,640.00View SEC Filing Icon  
7/16/2021Milton C. Ault IIIMajor ShareholderBuy600$6.23$3,738.00View SEC Filing Icon  
7/14/2021Milton C. Ault IIIMajor ShareholderBuy5,000$6.74$33,700.00View SEC Filing Icon  
7/12/2021Milton C. Ault IIIMajor ShareholderBuy8,100$6.15$49,815.00View SEC Filing Icon  
7/8/2021Milton C. Ault IIIMajor ShareholderBuy2,000$6.08$12,160.00View SEC Filing Icon  
7/6/2021Milton C. Ault IIIMajor ShareholderBuy7,000$7.07$49,490.00View SEC Filing Icon  
6/28/2021Milton C. Ault IIIMajor ShareholderBuy9,000$9.61$86,490.00View SEC Filing Icon  
6/25/2021Milton C. Ault IIIMajor ShareholderBuy14,000$8.79$123,060.00View SEC Filing Icon  
6/22/2021Milton C. Ault IIIMajor ShareholderBuy74,000$9.29$687,460.00
See Full Table
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Alzamend Neuro (NASDAQ:ALZN)

0.95% of Alzamend Neuro stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALZN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alzamend Neuro Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/11/2022RFG Advisory LLC250,000$0.31M0.0%N/A0.277%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd78,465$97K0.0%N/A0.087%Search for SEC Filing on Google Icon
4/22/2022Truist Financial Corp2,314,907$2.85M0.0%N/A2.569%Search for SEC Filing on Google Icon
2/17/2022Virtu Financial LLC23,079$44K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP163,774$0.31M0.0%N/A0.184%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC13,685$26K0.0%N/A0.015%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC29,791$56K0.0%N/A0.034%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC116,666$0.22M0.0%N/A0.131%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC31,600$97K0.0%N/A0.036%Search for SEC Filing on Google Icon
11/16/2021Jane Street Group LLC54,396$0.17M0.0%-59.3%0.063%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP172,913$0.53M0.0%N/A0.199%Search for SEC Filing on Google Icon
11/16/2021Warberg Asset Management LLC14,000$43K0.0%N/A0.016%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC46,669$0.14M0.0%+97.1%0.054%Search for SEC Filing on Google Icon
11/15/2021Sassicaia Capital Advisers LLC93,762$0.29M0.8%N/A0.108%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC15,402$0.14M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC23,672$0.21M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC44,600$0.39M0.0%N/A0.052%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP57,030$0.50M0.0%N/A0.067%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alzamend Neuro logo
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline includes AL001, an ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's and other neurodegenerative diseases, and psychiatric disorders; and AL002, a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Read More on Alzamend Neuro

Today's Range

Now: $0.92
Low: $0.90
High: $0.98

50 Day Range

MA: $1.05
Low: $0.88
High: $1.35

52 Week Range

Now: $0.92
Low: $0.80
High: $33.55


432,422 shs

Average Volume

1,016,499 shs

Market Capitalization

$83.16 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Alzamend Neuro?

Alzamend Neuro's top insider shareholders include:
  1. Milton C Ault III (Major Shareholder)
  2. Mark Gustafson (Director)
  3. L Mary Smith (Insider)
Learn More about top insider investors at Alzamend Neuro.

Who are the major institutional investors of Alzamend Neuro?

Alzamend Neuro's top institutional shareholders include:
  1. Truist Financial Corp — 2.57%
  2. RFG Advisory LLC — 0.28%
  3. Qube Research & Technologies Ltd — 0.09%
  4. Simplex Trading LLC — 0.00%
  5. Group One Trading L.P. — 0.00%
  6. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Alzamend Neuro stock.

Which institutional investors are selling Alzamend Neuro stock?

Within the last quarter, ALZN stock was sold by these institutional investors:
  1. Group One Trading L.P.
  2. Simplex Trading LLC
  3. Cutler Group LP
Within the previous year, company insiders that have sold Alzamend Neuro company stock include:
  1. Milton C Ault III (Major Shareholder)
  2. Mark Gustafson (Director)
  3. L Mary Smith (Insider)
Learn More investors selling Alzamend Neuro stock.

Which institutional investors are buying Alzamend Neuro stock?

Within the previous quarter, ALZN stock was acquired by institutional investors including:
  1. Truist Financial Corp
  2. RFG Advisory LLC
  3. Qube Research & Technologies Ltd
Bargain in Today's Market (SHOCKING)
This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...

Click Here Now (Before It's Too Late!)